Technical Analysis for COG - Cambridge Cognition Hold
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | -1.35% | |
| 50 DMA Resistance | Bearish | -1.35% | |
| Shooting Star Candlestick | Bearish | -1.35% | |
| Lizard Bearish | Bearish Day Trade Setup | -1.35% | |
| 180 Bearish Setup | Bearish Swing Setup | -1.35% | |
| Doji - Bearish? | Reversal | -1.35% | |
| New Uptrend | Bullish | -1.35% | |
| Stochastic Buy Signal | Bullish | -1.35% | |
| Doji - Bearish? | Reversal | -1.35% | |
| Oversold Stochastic | Weakness | -1.35% |
| Alert | Time |
|---|---|
| Gapped Up (Full) | about 1 hour ago |
| Up 1% | about 1 hour ago |
| 10 DMA Resistance | about 1 hour ago |
| Rose Above 10 DMA | about 20 hours ago |
| Up 1% | about 20 hours ago |
Get a Trading Sidekick!
Cambridge Cognition Hold Description
Cambridge Cognition Holdings plc and its subsidiaries develop and commercialize computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company's segments include Pharmaceutical Clinical Trials, Academic Research and Healthcare Technology. The Pharmaceutical Clinical Trials segment includes products and services for use in regulated pharmaceutical clinical trials. The Academic Research segment includes cognitive test products for researchers working in a non-regulated environment, typically in academia. The Healthcare Technology segment includes medical software for use in healthcare delivery settings. The Company is a provider of validated touchscreen cognitive assessments for clinical trials. The Company's product, CANTAB Mobile is a Class II medical device, used to identify patients exhibiting the early signs of Alzheimer's disease. It also offers Cantab Insight for dementia assessment in secondary care.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Healthcare Software Iron Pharmaceutical Disease Clinic Earl Medical Device Pharmaceutical Industry Clinical Trial Healthcare Technology Alzheimer's Disease Eim Technology Segment Dementia E Assessment Clinical Pharmacology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 104.0 |
| 52 Week Low | 47.2316 |
| Average Volume | 61,073 |
| 200-Day Moving Average | 67.61 |
| 50-Day Moving Average | 53.62 |
| 20-Day Moving Average | 53.56 |
| 10-Day Moving Average | 52.10 |
| Average True Range | 1.69 |
| RSI (14) | 35.06 |
| ADX | 25.03 |
| +DI | 24.83 |
| -DI | 17.45 |
| Chandelier Exit (Long, 3 ATRs) | 52.92 |
| Chandelier Exit (Short, 3 ATRs) | 55.08 |
| Upper Bollinger Bands | 56.98 |
| Lower Bollinger Band | 50.14 |
| Percent B (%b) | 0.27 |
| BandWidth | 12.77 |
| MACD Line | -0.73 |
| MACD Signal Line | -0.51 |
| MACD Histogram | -0.2185 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 54.55 | ||||
| Resistance 3 (R3) | 54.60 | 53.80 | 54.13 | ||
| Resistance 2 (R2) | 53.80 | 53.15 | 53.78 | 53.98 | |
| Resistance 1 (R1) | 52.90 | 52.75 | 52.85 | 52.85 | 53.84 |
| Pivot Point | 52.10 | 52.10 | 52.08 | 52.08 | 52.10 |
| Support 1 (S1) | 51.20 | 51.45 | 51.15 | 51.15 | 50.16 |
| Support 2 (S2) | 50.40 | 51.05 | 50.38 | 50.02 | |
| Support 3 (S3) | 49.50 | 50.40 | 49.88 | ||
| Support 4 (S4) | 49.45 |
